| Pfizer AG - Ibrance 100 mg, Hartkapseln | | 66138 | | 02 | | Ibrance 100 mg | | Hartkapseln | | L01EF01 | | | | 31.01.2017 | | |
| | Composition | | palbociclibum 100 mg, cellulosum microcristallinum, lactosum monohydricum 74.367 mg, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, E 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.71 mg. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | Ammoniae Solutio | 28 | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | Drucktinte | | Lactose Monohydrate | 74.367 mg | | | | | | | Sodium | 1.71 mg | | | Per Centum | | | | | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Simeticone | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 21 | 1973.56 | 2162.80 | A | LS | Oui |
|
|
